La cadena de opciones muestra datos clave de las opciones de acciones de Apollomics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Apollomics..

Apollomics (NASDAQ:APLM) Bolsa, Cadena de Opciones

Apollomics

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Apollomics Inc. - Class A Ordinary Shares

Apollomics Inc

Editor&#8217;s Note: This article has been updated to include a statement from Zelle.
The Consumer Financial Protection Bureau <a href="https://www.benzinga.com/news/legal/24/12/42687945/zelle-became-a-gold-mine-for-fraudsters-consumer-financial-protection-bureau-lawsuit">dropped its lawsuit</a> against JPMorgan Chase &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) and Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) on Tuesday concerning the banks&#8217; alleged failure to prevent fraud on Zelle. The Trump Administration has <a href="https://www.benzinga.com/news/25/02/44028664/trump-says-he-shut-down-the-ultra-left-cfpb-after-bankers-and-loan-officers-called-him-almost-crying">wound down CFPB cases</a> in recent weeks.
What Happened: The agency dismissed its case against the banks and Early Warning Services, Zelle&#8217;s parent company, CNBC <a href="https://www.cnbc.com/2025/03/04/cfpb-drops-jpmorgan-bank-of-america-wells-fargo-lawsuit.html">reports</a>. The lawsuit was originally brought in December during the Biden Administration.
The lawsuit alleged that banks did not do enough to protect and reimburse consumers from fraud on Zelle. The defendants allegedly rushed to launch Zelle without implementing sufficient anti-fraud protections. Because the cases were dismissed with prejudice, the agency will not bring similar charges against the banks again.
A Zelle spokesperson said, "We welcome the CFPB's decision to drop its lawsuit against the Zelle network. As we've said before, this lawsuit was without merit and legally and factually flawed. We look forward to continuing to provide Zelle, a trusted service, to 151 million enrolled American consumer and small business accounts."
The CFPB&#8217;s December <a href="https://files.consumerfinance.gov/f/documents/cfpb_Zelle-Complaint_2024-12.pdf">filing</a> said that 210,000 Bank of America customers experienced over $290 million in collective losses, 420,000 Chase customers lost over $360 million and 280,000 Wells Fargo customers were defrauded of over $220 million since 2017.
Reactions: The Trump administration has ended several consumer protection cases in recent weeks. Elon Musk, senior advisor to Trump, previously <a href="https://x.com/elonmusk/status/1861644897490751865">said</a> he&#8217;d like to &#8220;delete&#8221; the CFPB.
The CFPB&#8217;s <a href="https://www.consumerfinance.gov/about-us/the-bureau/" target="_blank" rel="noopener">mission</a> is to &#8220;protect consumers from unfair, deceptive, or abusive practices and take action against companies that break the law.&#8221;
Political figures reacted to the cases dropped by the agency.
&#8220;The CFPB makes up just 0.01% of the federal budget, yet it has returned $21 BILLION to American taxpayers,&#8221; Congressman Bill Foster (D-IL) <a href="https://x.com/RepBillFoster/status/1896672481190023622">said</a>. &#8220;Still, Trump &amp; Musk want to shut it down and make it easier for scammers to rip you off.&#8221;
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a></li>
</ul>
Photo: Shutterstock

Equities

Government

News

Legal

CFPB Drops Zelle Fraud Reimbursement Case Against JPMorgan, Wells Fargo (UPDATED)

"We made significant progress in February across every layer of our platform, from expanding our footprint to developing digital infrastructure and upgrading our ASIC fleet," said Asher Genoot, CEO of Hut 8.

Hut 8 February 2025 Bitcoin Produced 46 BTC Vs. 65 BTC In January 2025

Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) has outperformed the market over the past 15 years by 6.66% on an annualized basis producing an average annual return of 17.93%. Currently, Teledyne Technologies has a market capitalization of $23.01 billion. 
Buying $1000 In TDY: If an investor had bought $1000 of TDY stock 15 years ago, it would be worth $11,860.70 today based on a price of $491.27 for TDY at the time of writing.
<h3>Teledyne Technologies's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741300224_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Teledyne Technologies Stock In The Last 15 Years

Scotiabank analyst Brandon Bingham maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Sector Outperform and lowers the price target from $218 to $210.

Price Target

Analyst Ratings

TRGP

Scotiabank Maintains Sector Outperform on Targa Resources, Lowers Price Target to $210

Intuitive Machines Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) shares are extending losses from the regular session in after-hours Thursday after the company&#8217;s moon lander experienced technical issues during its <a href="https://www.benzinga.com/25/03/44176176/intuitive-machines-stock-falls-after-uncertain-athena-moon-landing-what-you-need-to-know">attempted moon landing</a>.
What Happened: Intuitive Machines shares fell more than 20% on Thursday after the company&#8217;s IM-2 mission Nova-C class lunar lander "Athena" experienced some issues around the time it was scheduled to touch down on the moon&#8217;s surface.
The selloff in shares accelerated after the market close as the company and NASA held a press conference to provide updates on the IM-2 mission.
&#8220;We&#8217;ve been very successful to this point, however I do have to tell you that we don&#8217;t believe we&#8217;re in the correct attitude on the surface of the moon yet again,&#8221; Intuitive Machines CEO Steve Altemus said in the press conference.
The Intuitive Machines IM-2 mission is the company&#8217;s second under NASA&#8217;s Commercial Lunar Payload Services initiative, which aims to lay the foundation for future human missions and a long-term human presence on the moon. The company&#8217;s moon lander "Odysseus" landed on the moon's surface last year, but was incorrectly positioned.
Altemus noted that communications are working properly on the moon lander, but there are issues with power generation and challenges with measurements from the laser range finders&nbsp;on the lander, which likely means that it&#8217;s laying on its side.
Intuitive Machines said it will provide further updates once it can confirm the position of the lander. The company plans to evaluate mission plans with NASA as more data becomes available.
LUNR Price Action: At the time of publication, <a href="http://benzinga.com/quote/lunr" target="_blank" rel="noreferrer noopener">Intuitive Machines shares</a> were down 25.22% after hours at $8.42 after falling more than 20% in the regular session, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/space/25/03/44158838/elon-musks-spacex-starships-next-test-flight-further-postponed-to-thursday">Elon Musk&#8217;s SpaceX Starship&#8217;s Next Test Flight Further Postponed To Thursday</a></li>
</ul>
Photo: Courtesy of Intuitive Machines.

SPACE

Movers

LUNR

Intuitive Machines Stock Is In Free Fall Thursday: What's Going On?

Scotiabank analyst Brandon Bingham maintains Plains All American (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) with a Sector Outperform and lowers the price target from $23 to $22.

Scotiabank Maintains Sector Outperform on Plains All American, Lowers Price Target to $22

Comstock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LODE#AMEX">LODE</a>) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is a 107.5 percent decrease over earnings of $0.80 per share from the same period last year. The company reported quarterly sales of $1.60 million which beat the analyst consensus estimate of $700.00 thousand by 128.43 percent. This is a 257.20 percent increase over sales of $447.65 thousand the same period last year.

Earnings

Earnings Beats

Earnings Misses

LODE

Comstock Q4 EPS $(0.06) Misses $(0.03) Estimate, Sales $1.60M Beat $700.00K Estimate

Scotiabank analyst Brandon Bingham maintains ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) with a Sector Outperform and lowers the price target from $109 to $102.

Scotiabank Maintains Sector Outperform on ONEOK, Lowers Price Target to $102

Scotiabank analyst Orest Wowkodaw maintains NexGen Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NXE#TSX">NXE</a>) with a Sector Outperform and lowers the price target from C$14.5 to C$12.

TSX:NXE

Scotiabank Maintains Sector Outperform on NexGen Energy, Lowers Price Target to C$12

Gap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) released its fourth-quarter results after Thursday's closing bell. Here's a look at the key details <a href="https://www.benzinga.com/pressreleases/25/03/n44179847/gap-inc-reports-fourth-quarter-and-fiscal-2024-results-provides-fiscal-2025-outlook">from the report. </a>
The Details: Gap reported quarterly earnings of 54 cents per share, which beat the analyst consensus estimate of 37 cents. Quarterly revenue clocked in at $4.1 billion, which beat the analyst consensus estimate of $4.07 billion.
Read Next: <a href="https://www.benzinga.com/general/market-summary/25/03/44172028/trade-turmoil-oil-slides-whats-driving-markets-thursday">Trade Turmoil, Oil Slides: What&#8217;s Driving Markets Thursday?</a>&nbsp;
For the fourth quarter, Gap reported: 
<ul>
<li>Net sales&nbsp;of&nbsp;$4.1 billion, down 3% compared to last year, inclusive of approximately 7% of negative impact from the weekly calendar shifts related to the loss of the 53rd&nbsp;week, as well as the loss of the additional week.
<ul>
<li>Store sales&nbsp;decreased 4% and&nbsp;online sales&nbsp;decreased 2% compared to last year, both inclusive of the negative impact related to the loss of the 53rd&nbsp;week.</li>
<li>Online sales&nbsp;represented 41% of total net sales.&nbsp;&nbsp;</li>
<li>Comparable sales&nbsp;were up 3%.</li>
</ul>
</li>
<li>Gross margin&nbsp;of 38.9% was flat versus last year.
<ul>
<li>Merchandise margin&nbsp;increased 20 basis points versus last year.</li>
<li>Rent, occupancy and depreciation (ROD) as a percent of sales deleveraged 20 basis points versus last year.</li>
</ul>
</li>
</ul>
&#8220;We ended the year delivering another successful quarter, exceeding financial expectations and gaining market share for the 8th consecutive quarter,&#8221; said CEO Richard Dickson. 
&#8220;For the full year 2024, Gap Inc. delivered positive comps in all four quarters, achieved one of the highest gross margins in the last 20 years and meaningfully increased operating margin versus the prior year,&#8221; Dickson added. 
GAP Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Gap shares were up 14.99% after hours at $22.36 Thursday.  
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a></li>
</ul>
Photo: Shutterstock

After-Hours Center

Gap Stock Pops After Q4 Results: Here's Why

The Cash Consideration represents a premium of 29%, and the Total Consideration represents a premium of up to 63%, to the WBA closing share price of $8.85 on December 9, 2024, the day prior to the first media reports regarding a potential transaction.
The transaction is expected to close in the fourth quarter calendar year 2025.
Upon completion of the transaction, WBA's common stock will no longer be listed on the Nasdaq Stock Market, and WBA will become a private company. &nbsp;
&nbsp;

Walgreens Boots Alliance Says Total Deal Consideration Consists of $11.45 Per Share in Cash And Additional Potential Value Of Up To $3.00 in Cash Per WBA Share From Future Monetization Of VillageMD Businesses

Scotiabank analyst Patrick Colville maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Sector Perform and lowers the price target from $275 to $240.

Scotiabank Maintains Sector Perform on MongoDB, Lowers Price Target to $240

Walgreens Boots Alliance Agrees To Be Acquired By Sycamore Partners; Total Value Of Transaction Represents Up To $23.7B

Scotiabank analyst Nicholas Yulico maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Sector Perform and lowers the price target from $22 to $21.

Scotiabank Maintains Sector Perform on Macerich, Lowers Price Target to $21

Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) has outperformed the market over the past 10 years by 14.63% on an annualized basis producing an average annual return of 25.48%. Currently, Veeva Systems has a market capitalization of $37.83 billion. 
Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $9,733.72 today based on a price of $233.00 for VEEV at the time of writing.
<h3>Veeva Systems's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741299310_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VEEV

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Amid an especially volatile <a href="https://www.benzinga.com/news/global/25/03/44176918/trump-delays-mexico-tariffs-for-a-month-economic-uncertainty-persits">start to 2025</a>, small-cap stocks have struggled. Are they now a buy at depressed valuations?
Russell 2000: The Russell 2000, as reflected by the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), has dropped nearly 15% since December 2024. This constitutes a market correction.
The Trump Administration has embraced domestic and foreign policies that Former Treasury Secretary&nbsp;Larry Summers&nbsp;<a href="https://www.benzinga.com/markets/equities/25/02/43649860/larry-summers-and-peter-schiff-warn-of-rising-inflation-risks-as-markets-slash-fed-rate-cut-expectations-most-sensitive-moment">labels as inflationary</a>. Higher prices could lead to higher interest rates, which disproportionately affect smaller companies with floating-rate debt.
The Russell index <a href="https://research.ftserussell.com/Analytics/FactSheets/Home/DownloadSingleIssue?issueName=US2000USD&amp;isManual=True">contains</a> 2,000 companies with an average market cap of around $1 billion. Higher-weighted components are likely to have outperformed the rest of the index and are not necessarily representative of the entire Russell 2000. Still, they provide a glimpse into how investors are valuing small-cap companies.
Here&#8217;s how the top stocks in the IWM have performed since the ETF&#8217;s correction began in December 2024:
Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>)
<ul>
<li>Dec. 2, 2024, Price: $150.92​</li>
<li>March 6, 2025, Price: $138.11​</li>
<li>Percentage Change: -8.49%</li>
</ul>
Insmed Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>)
<ul>
<li>Dec. 2, 2024, Price: $72.42​</li>
<li>March 6, 2025, Price: $75.02​</li>
<li>Percentage Change: +3.59%​</li>
</ul>
Vaxcyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>)
<ul>
<li>Dec. 2, 2024, Price: $91.60​</li>
<li>March 6, 2025, Price: $74.81</li>
<li>Percentage Change: -18.33%​</li>
</ul>
SouthState Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NASDAQ">SSB</a>)
<ul>
<li>Dec. 2, 2024, Price: $109.35</li>
<li>March 6, 2025, Price: $92.37</li>
<li>Percentage Change: -15.53%​</li>
</ul>
FTAI Aviation Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>)
<ul>
<li>Dec. 2, 2024, Price: $166.8​</li>
<li>March 6, 2025, Price: $108.2​8</li>
<li>Percentage Change: -35.08%​</li>
</ul>
Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)
<ul>
<li>Dec. 2, 2024, Price: $24.16</li>
<li>March 6, 2025, Price: $18.66</li>
<li>Percentage Change: -22.76%​</li>
</ul>
Applied Industrial Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>)
<ul>
<li>Dec. 2, 2024, Price: $272.91</li>
<li>March 6, 2025, Price: $229.00</li>
<li>Percentage Change: -16.09%​</li>
</ul>
Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>)
<ul>
<li>Dec. 2, 2024, Price: $47.80​</li>
<li>March 6, 2025, Price: $42.07</li>
<li>Percentage Change: -11.99%​</li>
</ul>
Ufp Industries Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPI#NASDAQ">UFPI</a>) and&nbsp;Fluor Corp.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) are also among the ETF&#8217;s top holdings.
Benzinga Edge evaluates stocks on a valuation, momentum and growth basis.
UFP, a holding company based in Grand Rapids, Michigan, performs well under the value criterion, scoring 78.64 out of 100. However, the stock does not have momentum, scoring 32.82. It is also not the fastest-growing company, grading 33.35. The stock is down 20.5% since Dec. 2, 2024.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/UFPI"><img loading="lazy" decoding="async" width="1024" height="229" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150724/Screenshot-2025-03-06-at-3.07.19-PM-1024x229.png" alt="" class="wp-image-812940" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150724/Screenshot-2025-03-06-at-3.07.19-PM-1024x229.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150724/Screenshot-2025-03-06-at-3.07.19-PM-300x67.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150724/Screenshot-2025-03-06-at-3.07.19-PM-768x172.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150724/Screenshot-2025-03-06-at-3.07.19-PM.png 1314w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Fluor, an engineering and construction firm, rates high according to its intrinsic value, scoring at 93.6. Still, recent price action indicates its growth and momentum prospects are not high, scoring 15.32 and 29.26, respectively. The stock is down 33.6% since Dec. 2, 2024.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/FLR"><img loading="lazy" decoding="async" width="1024" height="232" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150443/Screenshot-2025-03-06-at-3.04.39-PM-1024x232.png" alt="" class="wp-image-812935" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150443/Screenshot-2025-03-06-at-3.04.39-PM-1024x232.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150443/Screenshot-2025-03-06-at-3.04.39-PM-300x68.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150443/Screenshot-2025-03-06-at-3.04.39-PM-768x174.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/06150443/Screenshot-2025-03-06-at-3.04.39-PM.png 1322w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<ul>
<li>Unlock the rest of the BZ Edge Rankings and see how <a href="https://www.benzinga.com/quote/fn">another small-cap stock stacks up</a>.</li>
</ul>
S&amp;P 500 Comparison: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which tracks 500 of the largest U.S. companies, has fared slightly better than the Russell 2000. The index is down around 2% since Dec. 2, 2024.
On an earnings basis, investors are trading the S&amp;P 500 at a much higher multiple than the Russell 2000. The S&amp;P as a whole is trading 21.63 times above earnings compared to the small-cap index&#8217;s 14.84 times. 
Also Read:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/03/44174230/short-seller-targets-gorilla-technology-group-stock-investors-take-profits">Short Seller Targets Gorilla Technology Group Stock, Investors Take Profits</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Broad U.S. Equity ETFs

ETFs

CRDO

FTAI

INSM

PCVX

RKLB

UFPI

Are Small-Cap Stocks A Buy After Russell 2000 Correction?

Trading Halt: Halted at 5:14:09 p.m. ET - Trading Halt: Halt News Pending

Scotiabank analyst Brandon Bingham maintains Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) with a Sector Outperform and raises the price target from $247 to $254.

Scotiabank Maintains Sector Outperform on Cheniere Energy, Raises Price Target to $254

Scotiabank analyst Brandon Bingham maintains Kinetik Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNTK#NYSE">KNTK</a>) with a Sector Outperform and lowers the price target from $62 to $60.

KNTK

Scotiabank Maintains Sector Outperform on Kinetik Holdings, Lowers Price Target to $60

Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) released its fourth-quarter results after Thursday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/03/b44179559/samsara-reports-fourth-quarter-and-full-fiscal-year-2025-financial-results">from the quarter.</a>
The Details:&nbsp;Samsara reported quarterly earnings of&nbsp;11 cents&nbsp;per share, which beat the analyst consensus estimate of&nbsp;seven cents. Quarterly revenues of $346.3 million beat the analyst consensus estimate of&nbsp;$335.37 million&nbsp;and grew from $276.274 million&nbsp;in the same period last year.
The company also reported ending ARR of $1.458 billion, representing 33% year-over-year adjusted growth, and 2,506 customers with ARR over $100,000, representing 36% year-over-year growth. 
Read Next: <a href="https://www.benzinga.com/general/market-summary/25/03/44172028/trade-turmoil-oil-slides-whats-driving-markets-thursday">Trade Turmoil, Oil Slides: What&#8217;s Driving Markets Thursday?</a>&nbsp;
&#8220;Fiscal year 2025 was another year of durable and efficient growth. We ended the year with close to $1.5 billion of ARR, achieving 33% year-over-year adjusted growth,&#8221; said Sanjit Biswas, CEO of Samsara. &#8220;We&#8217;re operating at a rare combination of growth, scale and profitability, and we see a large market opportunity ahead of us.&#8221;
Outlook: Samsara sees first-quarter EPS between five cents and six cents, versus the five cents estimate, and revenue in a range of $350 million to $352 million, versus the $351.35 million estimate.
IOT Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Samsara shares were down 3.53% after-hours at $40.40 Thursday.  
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a></li>
</ul>
Image: Courtesy of Samsara, Inc.

Tech

Samsara Shares Drop Despite Better-Than-Expected Q4 Results

Press Releases

Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference

Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial

Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data

Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress

Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLM – A Must-Watch This Week!

Apollomics' Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

General

Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Health Care

Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Comments

Apollomics

Apollomics (APLM) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL